N6-methyladenine modification in noncoding RNAs and its function in cancer

Area of Science:

• Molecular Biology
• Epigenetics
• Oncology

Background:

• Non-coding RNAs (ncRNAs) are key regulators of biological processes.
• N6-methyladenosine (m6A) modification is a prevalent RNA modification impacting RNA metabolism.
• Dysregulation of ncRNAs and m6A is implicated in cancer progression.

Purpose of the Study:

• To review the regulatory mechanisms between m6A methylation and ncRNAs.
• To highlight the impact of the m6A-ncRNA interaction on cancer biology.
• To explore their potential as prognostic markers and therapeutic targets in cancer.

Main Methods:

• Literature review of recent research on m6A modification and ncRNAs in cancer.
• Analysis of regulatory pathways involving m6A and ncRNAs.
• Synthesis of findings on their roles in tumor gene expression and cancer development.

Main Results:

• m6A modification extensively influences ncRNA function and stability.
• The interaction between m6A and ncRNAs plays a pivotal role in cancer development.
• Specific ncRNAs are regulated by m6A, affecting oncogenic or tumor-suppressive pathways.

Conclusions:

• The interplay between m6A and ncRNAs offers novel insights into cancer gene regulation.
• m6A modification and ncRNAs represent promising prognostic biomarkers for various cancers.
• Targeting the m6A-ncRNA axis presents a potential therapeutic strategy for cancer treatment.